Clinical Trial Update: Monitoring Breast Cancer Immunotherapy Treatment With Advanced Positron Emission Tomography Magnetic Resonance Imaging (PET/MRI) [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 trial at the University of Alabama at Birmingham is exploring PET/MRI imaging to monitor response to immunotherapy in patients with triple-negative br…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Triple Negative Breast Cancer | EARLY_Phase 1 | Status: RECRUITING